Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation

Computers in Biology and Medicine

Volumn 65, Issue , 2015, Pages 103-113

  Beliveau, Pascale ^a,b   Cheriet, Farida ^b   Anderson, Stasia A ^a   Taylor, Joni L ^a   Arai, Andrew E ^a   Hsu, Li Yueh ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

Author keywords

Aging; Computer quantification; Diffuse myocardial fibrosis; Gadolinium; Magnetic resonance imaging; Texture analysis

Indexed keywords

AGING OF MATERIALS; COLLAGEN; GADOLINIUM; HISTOLOGY; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETISM; RATS; RESONANCE; SCANNING;

CARDIAC MAGNETIC RESONANCE; COMPUTER QUANTIFICATION; GRAY LEVEL CO-OCCURRENCE MATRIX; MYOCARDIAL FIBROSIS; MYOCARDIAL INFARCTION; QUANTITATIVE ASSESSMENTS; STANDARD DEVIATION; TEXTURE ANALYSIS;

IMAGE TEXTURE;

COLLAGEN; GADOLINIUM; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTRAST ENHANCEMENT CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; EX VIVO STUDY; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; IMAGE ANALYSIS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; STAINING; AGING; ANIMAL; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; FIBROSIS; FISCHER 344 RAT; HEART INFARCTION; HUMAN; IMAGE PROCESSING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; RADIOGRAPHY;

AGING; ANIMALS; CONTRAST MEDIA; FIBROSIS; GADOLINIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RADIOGRAPHY; RATS; RATS, INBRED F344;

EID: 84941267829     PISSN: 00104825     EISSN: 18790534     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2015.07.027     Document Type: Article

References (48)

1. Mewton N., Liu C.Y., Croisille P., Bluemke D., Lima J.A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2011, 57:891-903.
2. Cheng S., Fernandes V.R., Bluemke D.A., McClelland R.L., Kronmal R.A., Lima J.A. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ. Cardiovasc. Imaging 2009, 2:191-198.
3. Neilan T.G., Coelho-Filho O.R., Shah R.V., Abbasi S.A., Heydari B., Watanabe E., Chen Y., Mandry D., Pierre-Mongeon F., Blankstein R., Kwong R.Y., Jerosch-Herold M. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc. Imaging 2013, 6:672-683.
4. Eghbali M., Robinson T.F., Seifter S., Blumenfeld O.O. Collagen accumulation in heart ventricles as a function of growth and aging. Cardiovasc. Res. 1989, 23:723-729.
5. Ellims A.H., Iles L.M., Ling L.H., Hare J.L., Kaye D.M., Taylor A.J. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J. Cardiovasc. Magn. Reson. 2012, 14:76.
6. Bluemke D.A. MRI of nonischemic cardiomyopathy. Am. J. Roentgenol. 2010, 195:935-940.
7. Shirani J., Pick R., Roberts W.C., Maron B.J. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J. Am. Coll. Cardiol. 2000, 35:36-44.
8. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., Bundy J., Finn J.P., Klocke F.J., Judd R.M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
9. Schelbert E.B., Hsu L.Y., Anderson S.A., Mohanty B.D., Karim S.M., Kellman P., Aletras A.H., Arai A.E. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ. Cardiovasc. Imaging 2010, 3:743-752.
10. Messroghli D.R., Nordmeyer S., Dietrich T., Dirsch O., Kaschina E., Savvatis K., Klein C., Berger F., Kuehne T. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping. Circ. Cardiovasc. Imaging 2011, 4:636-640.
11. Salerno M., Kramer C.M. Advances in parametric mapping with CMR imaging. JACC Cardiovasc. Imaging 2013, 6:806-822.
12. Ugander M., Oki A.J., Hsu L.Y., Kellman P., Greiser A., Aletras A.H., Sibley C.T., Chen M.Y., Bandettini W.P., Arai A.E. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur. Heart J. 2012, 33:1268-1278.
13. Broberg C.S., Chugh S.S., Conklin C., Sahn D.J., Jerosch-Herold M. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ. Cardiovasc. Imaging 2010, 3:727-734.
14. Setser R.M., Bexell D.G., O'Donnell T.P., Stillman A.E., Lieber M.L., Schoenhagen P., White R.D. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J. Magn. Reson. Imaging 2003, 18:434-441.
15. Sado D.M., Flett A.S., Banypersad S.M., White S.K., Maestrini V., Quarta G., Lachmann R.H., Murphy E., Mehta A., Hughes D.A., McKenna W.J., Taylor A.M., Hausenloy D.J., Hawkins P.N., Elliott P.M., Moon J.C. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012, 98:1436-1441.
16. Flett A.S., Hayward M.P., Ashworth M.T., Hansen M.S., Taylor A.M., Elliott P.M., McGregor C., Moon J.C. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010, 122:138-144.
17. Iles L., Pfluger H., Phrommintikul A., Cherayath J., Aksit P., Gupta S.N., Kaye D.M., Taylor A.J. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J. Am. Coll. Cardiol. 2008, 52:1574-1580.
18. Kellman P., Wilson J.R., Xue H., Bandettini W.P., Shanbhag S.M., Druey K.M., Ugander M., Arai A.E. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J. Cardiovasc. Magn. Reson. 2012, 14:64.
19. Su M.Y., Wu V.C., Yu H.Y., Lin Y.H., Kuo C.C., Liu K.L., Wang S.M., Chueh S.C., Lin L.Y., Wu K.D., Tseng W.Y., Contrast-enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism. J. Magn. Reson. Imaging 2012, 35:1349-1355.
20. Sibley C.T., Noureldin R.A., Gai N., Nacif M.S., Liu S., Turkbey E.B., Mudd J.O., van der Geest R.J., Lima J.A., Halushka M.K., Bluemke D.A. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 2012, 265:724-732.
21. Abdullah O.M., Drakos S.G., Diakos N.A., Wever-Pinzon O., Kfoury A.G., Stehlik J., Selzman C.H., Reid B.B., Brunisholz K., Verma D.R., Myrick C., Sachse F.B., Li D.Y., Hsu E.W. Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR Biomed. 2014, 27:1378-1386.
22. Bun S.S., Kober F., Jacquier A., Espinosa L., Kalifa J., Bonzi M.F., Kopp F., Lalevee N., Zaffran S., Deharo J.C., Cozzone P.J., Bernard M. Value of in vivo T2 measurement for myocardial fibrosis assessment in diabetic mice at 11.75T. Investig. Radiol. 2012, 47:319-323.
23. Eftestol T., Woie L., Engan K., Kvaloy J.T., Nilsen D.W.T., Orn S. Texture analysis to assess risk of serious arrhythmias after myocardial infarction. Comput. Cardiol. (Cinc.) 2012, 39:365-368.
24. Kotu L.P., Engan K., Skretting K., Maloy F., Orn S., Woie L., Eftestol T. Probability mapping of scarred myocardium using texture and intensity features in CMR images. Biomed. Eng. Online 2013, 12:91.
25. Thornhill R.E., Cocker M., Dwivedi G., Dennie C., Fuller L., Dick A., Ruddy T., Pena E. Quantitative texture features as objective metrics of enhancement heterogeneity in hypertrophic cardiomyopathy. J. Cardiovasc. Magn. Reson. 2014, 16:P351.
26. Lopez-De Leon A., Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J. Histochem. Cytochem. 1985, 33:737-743.
27. Yabusaki K., Faits T., McMullen E., Figueiredo J.L., Aikawa M., Aikawa E. A novel quantitative approach for eliminating sample-to-sample variation using a hue saturation value analysis program. Plos One 2014, 9:e89627.
28. Foley J.D., VanDam A. Fundamentals of Interactive Computer Graphics 1982, Addison-Wesley Longman Publishing Co., Inc.
29. Haralick R.M., Shanmugan K., Dinstein I. Textural features for image classification. IEEE Trans. Syst. Man Cybern. I 1973, SMC-3:610-621.
30. Reimer K.A., Lowe J.E., Rasmussen M.M., Jennings R.B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977, 56:786-794.
31. Ding W.Y., Liu L., Wang Z.H., Tang M.X., Ti Y., Han L., Zhang L., Zhang Y., Zhong M., Zhang W. FP-receptor gene silencing ameliorates myocardial fibrosis and protects from diabetic cardiomyopathy. J. Mol. Med. (Berl.) 2014, 92:629-640.
32. Caudron J., Mulder P., Nicol L., Richard V., Thuillez C., Dacher J.N. MR relaxometry and perfusion of the myocardium in spontaneously hypertensive rat: correlation with histopathology and effect of anti-hypertensive therapy. Eur. Radiol. 2013, 23:1871-1881.
33. Ishizu T., Seo Y., Kameda Y., Kawamura R., Kimura T., Shimojo N., Xu D., Murakoshi N., Aonuma K. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease. Hypertension 2014, 63:500-506.
34. Li W., Lu M., Banerjee S., Zhong J., Ye A., Molter J., Yu X. Ex vivo diffusion tensor MRI reflects microscopic structural remodeling associated with aging and disease progression in normal and cardiomyopathic Syrian hamsters. NMR Biomed. 2009, 22:819-825.
35. Anversa P., Capasso J.M. Cellular basis of aging in the mammalian heart. Scanning Microsc. 1991, 5:1065-1073. (discussion 1073-1064).
36. Sangaralingham S.J., Ritman E.L., McKie P.M., Ichiki T., Lerman A., Scott C.G., Martin F.L., Harders G.E., Bellavia D., Burnett J.C. Cardiac micro-computed tomography imaging of the aging coronary vasculature. Circ. Cardiovasc. Imaging 2012, 5:518-524.
37. Walker E.M., Nillas M.S., Mangiarua E.I., Cansino S., Morrison R.G., Perdue R.R., Triest W.E., Wright G.L., Studeny M., Wehner P., Rice K.M., Blough E.R. Age-associated changes in hearts of male Fischer 344/Brown Norway F1 rats. Ann. Clin. Lab. Sci. 2006, 36:427-438.
38. Liu C.Y., Liu Y.C., Wu C., Armstrong A., Volpe G.J., van der Geest R.J., Liu Y., Hundley W.G., Gomes A.S., Liu S., Nacif M., Bluemke D.A., Lima J.A. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 2013, 62:1280-1287.
39. Moravsky G., Ofek E., Rakowski H., Butany J., Williams L., Ralph-Edwards A., Wintersperger B.J., Crean A. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. JACC Cardiovasc. Imaging 2013, 6:587-596.
40. Flett A.S., Hasleton J., Cook C., Hausenloy D., Quarta G., Ariti C., Muthurangu V., Moon J.C. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc. Imaging 2011, 4:150-156.
41. Beek A.M., Bondarenko O., Afsharzada F., van Rossum A.C. Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome. J. Cardiovasc. Magn. Reson. 2009, 11:6.
42. Baron N., Kachenoura N., Cluzel P., Frouin F., Herment A., Grenier P., Montalescot G., Beygui F. Comparison of various methods for quantitative evaluation of myocardial infarct volume from magnetic resonance delayed enhancement data. Int. J. Cardiol. 2013, 167:739-744.
43. Mikami Y., Kolman L., Joncas S.X., Stirrat J., Scholl D., Rajchl M., Lydell C.P., Weeks S.G., Howarth A.G., White J.A. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy. J. Cardiovasc. Magn. Reson. 2014, 16:85.
44. Ambale-Venkatesh B., Lima J.A. Cardiac MRI: a central prognostic tool in myocardial fibrosis. Nat. Rev. Cardiol. 2015, 12:18-29.
45. Mahrholdt H., Wagner A., Judd R.M., Sechtem U., Kim R.J. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur. Heart J. 2005, 26:1461-1474.
46. Hsu L.Y., Natanzon A., Kellman P., Hirsch G.A., Aletras A.H., Arai A.E. Quantitative myocardial infarction on delayed enhancement MRI. Part I: animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J. Magn. Reson. Imaging 2006, 23:298-308.
47. Whittaker P., Kloner R.A., Boughner D.R., Pickering J.G. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res. Cardiol. 1994, 89:397-410.
48. de Jong S., van Veen T.A., de Bakker J.M., van Rijen H.V. Monitoring cardiac fibrosis: a technical challenge. Neth. Heart J. 2012, 20:44-48.